In an FDA October coronavirus press release, 642 revisions were made to Emergency Use Authorizations. Additionally, 415 tests and sample collection devices were authorized by the FDA under emergency use authorizations (EUAs). While it may seem like good news that 415 new tests exist, this move, [along with the 642 revisions of Emergency Use Authorizations] indicates that the FDA may have financially incentivized priorities other than fully completing testing before releasing such devices.